Endometrial cancer prevention

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There are 200,000 new cases of endometrial cancer diagnosed worldwide each year leading to 50,000 deaths (Mohr et al. 2007). In the U.S., endometrial cancer is the most common malignancy of the lower female genital tract with an incidence of 40,100 per year, nearly four times as common as cervical cancer (Jemal et al. 2008). Despite the relatively high incidence of endometrial cancer, the prognosis for endometrial cancer is better than for most other gynecologic malignancies. Even though endometrial cancer is greater than 1.7 times more common than ovarian cancer, the disease kills less than half as many women. Approximately 7,470 deaths occur due to endometrial cancer each year, compared to 15,520 deaths annually from ovarian cancer (Jemal et al. 2008). Endometrial cancer can occur in a wide age range, with the median age at diagnosis of 61 years (Plaxe and Saltzstein 1997; Sherman and Devesa 2003). Three quarters of the women diagnosed with endometrial cancer are post-menopausal. In addition to age, race and country of origin also appear to be factors. Eastern Asia and Western Africa have incidence rates nearly ten times lower than North America (IARC 2005). The lowest incidence rates are found in Eastern Asia (2.2 cases per 100,000), Western Africa (2.2 cases per 100,000), and South-Central Asia (2.3 cases per 100,000); whereas the highest rates are found in North America (22 cases per 100,000), Northern Europe (12.2 cases per 100,000), and Western Europe (12.5 cases per 100,000) (IARC 2005).

Original languageEnglish (US)
Title of host publicationFundamentals of Cancer Prevention
PublisherSpringer Berlin Heidelberg
Pages475-494
Number of pages20
ISBN (Print)9783540242123
DOIs
StatePublished - 2005

Fingerprint

Endometrial Neoplasms
Western Africa
Far East
Incidence
North America
Ovarian Neoplasms
Ovarian Diseases
Central Asia
Eastern Africa
Uterine Cervical Neoplasms
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Garcia, F. A., & Chambers, S. K. (2005). Endometrial cancer prevention. In Fundamentals of Cancer Prevention (pp. 475-494). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-68986-7_18

Endometrial cancer prevention. / Garcia, Francisco A; Chambers, Setsuko K.

Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, 2005. p. 475-494.

Research output: Chapter in Book/Report/Conference proceedingChapter

Garcia, FA & Chambers, SK 2005, Endometrial cancer prevention. in Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, pp. 475-494. https://doi.org/10.1007/978-3-540-68986-7_18
Garcia FA, Chambers SK. Endometrial cancer prevention. In Fundamentals of Cancer Prevention. Springer Berlin Heidelberg. 2005. p. 475-494 https://doi.org/10.1007/978-3-540-68986-7_18
Garcia, Francisco A ; Chambers, Setsuko K. / Endometrial cancer prevention. Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, 2005. pp. 475-494
@inbook{db73b1f3d0c5474985539004701e0c5a,
title = "Endometrial cancer prevention",
abstract = "There are 200,000 new cases of endometrial cancer diagnosed worldwide each year leading to 50,000 deaths (Mohr et al. 2007). In the U.S., endometrial cancer is the most common malignancy of the lower female genital tract with an incidence of 40,100 per year, nearly four times as common as cervical cancer (Jemal et al. 2008). Despite the relatively high incidence of endometrial cancer, the prognosis for endometrial cancer is better than for most other gynecologic malignancies. Even though endometrial cancer is greater than 1.7 times more common than ovarian cancer, the disease kills less than half as many women. Approximately 7,470 deaths occur due to endometrial cancer each year, compared to 15,520 deaths annually from ovarian cancer (Jemal et al. 2008). Endometrial cancer can occur in a wide age range, with the median age at diagnosis of 61 years (Plaxe and Saltzstein 1997; Sherman and Devesa 2003). Three quarters of the women diagnosed with endometrial cancer are post-menopausal. In addition to age, race and country of origin also appear to be factors. Eastern Asia and Western Africa have incidence rates nearly ten times lower than North America (IARC 2005). The lowest incidence rates are found in Eastern Asia (2.2 cases per 100,000), Western Africa (2.2 cases per 100,000), and South-Central Asia (2.3 cases per 100,000); whereas the highest rates are found in North America (22 cases per 100,000), Northern Europe (12.2 cases per 100,000), and Western Europe (12.5 cases per 100,000) (IARC 2005).",
author = "Garcia, {Francisco A} and Chambers, {Setsuko K}",
year = "2005",
doi = "10.1007/978-3-540-68986-7_18",
language = "English (US)",
isbn = "9783540242123",
pages = "475--494",
booktitle = "Fundamentals of Cancer Prevention",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Endometrial cancer prevention

AU - Garcia, Francisco A

AU - Chambers, Setsuko K

PY - 2005

Y1 - 2005

N2 - There are 200,000 new cases of endometrial cancer diagnosed worldwide each year leading to 50,000 deaths (Mohr et al. 2007). In the U.S., endometrial cancer is the most common malignancy of the lower female genital tract with an incidence of 40,100 per year, nearly four times as common as cervical cancer (Jemal et al. 2008). Despite the relatively high incidence of endometrial cancer, the prognosis for endometrial cancer is better than for most other gynecologic malignancies. Even though endometrial cancer is greater than 1.7 times more common than ovarian cancer, the disease kills less than half as many women. Approximately 7,470 deaths occur due to endometrial cancer each year, compared to 15,520 deaths annually from ovarian cancer (Jemal et al. 2008). Endometrial cancer can occur in a wide age range, with the median age at diagnosis of 61 years (Plaxe and Saltzstein 1997; Sherman and Devesa 2003). Three quarters of the women diagnosed with endometrial cancer are post-menopausal. In addition to age, race and country of origin also appear to be factors. Eastern Asia and Western Africa have incidence rates nearly ten times lower than North America (IARC 2005). The lowest incidence rates are found in Eastern Asia (2.2 cases per 100,000), Western Africa (2.2 cases per 100,000), and South-Central Asia (2.3 cases per 100,000); whereas the highest rates are found in North America (22 cases per 100,000), Northern Europe (12.2 cases per 100,000), and Western Europe (12.5 cases per 100,000) (IARC 2005).

AB - There are 200,000 new cases of endometrial cancer diagnosed worldwide each year leading to 50,000 deaths (Mohr et al. 2007). In the U.S., endometrial cancer is the most common malignancy of the lower female genital tract with an incidence of 40,100 per year, nearly four times as common as cervical cancer (Jemal et al. 2008). Despite the relatively high incidence of endometrial cancer, the prognosis for endometrial cancer is better than for most other gynecologic malignancies. Even though endometrial cancer is greater than 1.7 times more common than ovarian cancer, the disease kills less than half as many women. Approximately 7,470 deaths occur due to endometrial cancer each year, compared to 15,520 deaths annually from ovarian cancer (Jemal et al. 2008). Endometrial cancer can occur in a wide age range, with the median age at diagnosis of 61 years (Plaxe and Saltzstein 1997; Sherman and Devesa 2003). Three quarters of the women diagnosed with endometrial cancer are post-menopausal. In addition to age, race and country of origin also appear to be factors. Eastern Asia and Western Africa have incidence rates nearly ten times lower than North America (IARC 2005). The lowest incidence rates are found in Eastern Asia (2.2 cases per 100,000), Western Africa (2.2 cases per 100,000), and South-Central Asia (2.3 cases per 100,000); whereas the highest rates are found in North America (22 cases per 100,000), Northern Europe (12.2 cases per 100,000), and Western Europe (12.5 cases per 100,000) (IARC 2005).

UR - http://www.scopus.com/inward/record.url?scp=84890009864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890009864&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-68986-7_18

DO - 10.1007/978-3-540-68986-7_18

M3 - Chapter

AN - SCOPUS:84890009864

SN - 9783540242123

SP - 475

EP - 494

BT - Fundamentals of Cancer Prevention

PB - Springer Berlin Heidelberg

ER -